Article Information
History
- September 27, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Maristella Pitzalis1,†,*,
- Maria Laura Idda1,†,*,
- Valeria Lodde2,
- Annalisa Loizedda1,
- Monia Lobina1,
- Magdalena Zoledzwieska1,
- Francesca Virdis1,
- Giuseppe Delogu2,
- Federica Pirinu2,
- Maria Giuseppina Marini1,
- Maura Mingoia1,
- Jessica Frau3,
- Lorena Lorefice3,
- Maria Fronza4,
- Daniele Carmagini4,
- Elisa Carta4,
- Valeria Orrù1,
- Sergio Uzzau5,
- Paolo Solla6,
- Federica Loi7,
- Marcella Devoto1,
- Maristella Steri1,
- Edoardo Fiorillo1,
- Matteo Floris2,
- Ignazio Roberto Zarbo6,^,
- Eleonora Cocco3,4,^ and
- Francesco Cucca2,^
- 1Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Cagliari
- 2Department of Biomedical Sciences, University of Sassari, Sassari
- 3Regional Multiple Sclerosis Center, ASSL Cagliari, ATS Sardegna, Cagliari
- 4Department of Medical Science and Public Health, University of Cagliari, Cagliari
- 5Department of Biomedical Sciences, University of Sassari - Unit of Clinical Microbiology, AOU Sassari, Sassari
- 6Department of Medical, Surgical and Experimental Sciences, University of Sassari - Neurology Unit, AOU Sassari, Sassari
- 7Osservatorio Epidemiologico Veterinario Regionale, Istituto Zooprofilattico Sperimentale della Sardegna, Cagliari
- 8Dipartimento di Medicina Traslazionale e di Precisione, Università la Sapienza, Rome, Italy
- ↵*Correspondence:
Maria Laura Idda, Maristella Pitzalis, marialaura.idda{at}irgb.cnr.it, maristella.pitzalis{at}irgb.cnr.it
Posted September 27, 2021.
Effect of different disease-modifying therapies on humoral response to BNT162b2 vaccine in Sardinian multiple sclerosis patients
